Filing Details

Accession Number:
0001209191-21-051884
Form Type:
5
Zero Holdings:
No
Publication Time:
2021-08-17 16:44:10
Reporting Period:
2021-06-30
Accepted Time:
2021-08-17 16:44:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
57725 Lannett Co Inc LCI Pharmaceutical Preparations (2834) 230787699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1262050 Jeffrey Farber 1775 John R Road
Troy MI 48083
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-14 38,125 $0.00 1,667,649 No 5 W Direct
Common Stock Acquisiton 2020-09-01 38,986 $0.00 1,706,635 No 5 A Direct
Common Stock Disposition 2021-02-10 320,000 $0.00 250,919 No 5 J Indirect 2019 GRAT
Common Stock Acquisiton 2021-02-10 320,000 $0.00 2,026,635 No 5 J Direct
Common Stock Disposition 2021-05-05 38,000 $0.00 0 No 5 J Indirect Farber Investment LLC
Common Stock Acquisiton 2021-05-05 19,000 $0.00 2,045,635 No 5 J Direct
Common Stock Acquisiton 2021-05-28 10,000 $4.37 2,055,635 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 W Direct
No 5 A Direct
No 5 J Indirect 2019 GRAT
No 5 J Direct
No 5 J Indirect Farber Investment LLC
No 5 J Direct
No 5 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 994,412 Indirect Jeffrey Farber Family Foundation
Common Stock 528,122 Indirect Farber Family LLC
Common Stock 300,000 Indirect 2020 GRAT
Common Stock 73,408 Indirect Jeffrey Farber, Custodian for Children
Common Stock 30,000 Indirect Jeffrey and Jennifer Farber Family Foundation
Common Stock 17,279 Indirect Jeffrey Farber, Joint Custodian
Footnotes
  1. On August 14, 2020, the Audrey Farber Roth IRA transferred 38,128 shares to Jeffrey Farber's IRA.
  2. This transaction represents an acquisition of shares for no value as part of the settlement of an estate by will.
  3. Represents restricted stock awards that vested in full on September 1, 2020, which were previously reported on a Form 4 filed on September 3, 2020
  4. On February 10, 2021, the 2019 GRAT transferred 320,000 shares to Jeffrey Farber's Trust.
  5. This transaction represents a transfer for no value by the Reporting Person.
  6. Jeffrey Farber disclaims beneficial ownership of these shares.
  7. On May 5, 2021, the Farber Investment LLC transferred 19,000 shares to Jeffrey Farber's Trust and 19,000 shares to David Farber's Trust.
  8. Represents shares purchased on the open market on May 28, 2021, which were previously reported on a Form 4 filed June 1, 2021